Clinical trial
Family Risk Analysis of Substance Use in Attention Deficit Hyperactivity…
NCT00181792 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00181792 |
|---|---|
| Title | Family Risk Analysis of Substance Use in Attention Deficit Hyperactivity Disorder (ADHD) Youth Treated With Concerta |
| Official title | Family Risk Analysis of Substance Use in ADHD Youth Treated With Concerta |
| Lead sponsor | Massachusetts General Hospital, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | ADHD, Smoking |
| Enrollment | 70 |
| Start date | May 1, 2005 |
| Primary completion | Aug 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Sep 16, 2005 |
| Last update posted | May 4, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: